Latest Hologic Inc (HOLX) Headlines Pre-Market
Post# of 35
Pre-Market Health Care Stocks Analysis: Medtronic, Abbott Laboratories, Hologic, and ArthroCare
PR Newswire - 1 hr 29 mins ago
On Wednesday, March 12, 2014, the NASDAQ Composite ended at 4,323.33, up 0.37%, the Dow Jones Industrial Average fell 0.07% to 16,340.08, and the S&P 500 closed at 1,868.20, up 0.03%. The gains were narrow based as four out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 687.90, down 0.01%, while the same has gained 3.36% in the last one month. Investor-Edge.com has initiated coverage on the following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Hologic Inc. (NASDAQ: HOLX), and ArthroCare Corporation (NASDAQ: ARTC). Free research on these four companies can be accessed at:
MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts
M2 - Thu Mar 13, 4:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wl9hj7/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. Countries in the Asia Pacific (APAC) region such as Japan and China and the South American country of Brazil will have growth rates that are more than double the global CAGR. This is primarily due to the increased market access of each country's population to healthcare resources and the increased adoption of more expensive core needle biopsy devices over fine needle aspiration devices. Scope - An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019. - Investigation of current and future market competition for biopsy devices. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Unmet Needs Market Opportunity Analysis Market Drivers and Barriers Competitive Assessment Pipeline Assessment Clinical Trial Analysis Current and Future Players Market Outlook Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/wl...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Biopsy Devices - US Analysis and Market Forecasts Research Report
M2 - Wed Mar 12, 3:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/66ts7p/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - US Analysis and Market Forecasts" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. While the global biopsy devices market is expected to see growth over the forecast period, there are several barriers that are dampening the intervention's potential adoption levels. Notably in the US, reimbursement for image guided breast biopsies has undergone some restructuring. The 2014 Medicare Fee Schedule Final Rule imposed drastic reimbursement cuts for these procedures which will have a significant effect on the adoption of more expensive vacuum assisted biopsy (VAB) devices. Scope - An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the US biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019. - Investigation of current and future market competition for biopsy devices - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/66...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Insider Trading Alert - TCBI, HUM And HOLX Traded By Insiders
at The Street - Tue Mar 11, 11:45AM CDT
Stocks with insider trader activity include TCBI, HUM and HOLX
Concise Analysis of the International In Vitro Diagnostic (IVD) Market - Forecast To 2017
M2 - Tue Mar 11, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nc4zfn/in_vitro) has announced the addition of the "Concise Analysis of the International In Vitro Diagnostic (IVD) Market - Forecast To 2017" report to their offering. The in vitro diagnostic market studied in this report has been segmented by technology, product type, application, end user, and geography. The technology market is further segmented into clinical chemistry, immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, and others, of which immunochemistry accounted for the largest share with 25.8% in 2010. By product type, the IVD market has segments like instruments, reagents, data management software/hardware, and services. Based on applications, the in vitro diagnostic market is segmented as diabetes, infectious diseases, oncology, cardiology, nephrology, auto-immune diseases, AIDS, drug testing, and others. Laboratory testing, hospital testing, academic (AMCs and university) testing, point-of-care testing, patient self-testing, and others comprise the end-user segment of the IVD market. The global in vitro diagnostic market was valued at $49.2 billion in 2012 and is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The IVD market is primarily driven by rising incidences of chronic and infectious diseases in emerging economies, a rapidly aging population, the rise in point-of-care testing, and the rising importance of personalized medicine. However, factors such as stringent regulatory frameworks and a shortage of budget and labor are restraining the growth of the market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 6 Global In Vitro Diagnostic Market, By Application 7 Global In Vitro Diagnostic Market, By End-User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc - Alere, Inc - Arkray, Inc - Bayer AG - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc - Biomerieux - Danaher Corporation - Diagnostica Stago Sas - Diasorin SPA - Hologic, Inc - Horiba, Ltd - Johnson & Johnson - Novartis International Ag - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc For more information visit http://www.researchandmarkets.com/research/nc4zfn/in_vitro
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2014 Analysis of the UK Hepatitis Diagnostics Market: Hospitals, Blood Banks, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
M2 - Mon Mar 10, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rjsvbf/2014_analysis_of) has announced the addition of the "2014 Analysis of the UK Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures" report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks - Public Health Labs In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics/Grifols - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/rj...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018 Out Now
M2 - Fri Mar 07, 5:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/4hmks6/global_isothermal) has announced the addition of the "Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018" report to their offering. The analysts forecast the Global Isothermal Nucleic Acid Amplification Technologies market will grow at a CAGR of 17.49 percent over the period 2013-2018. One of the key factors contributing to this market growth is the technological advances being made in this domain. The Global Isothermal Nucleic Acid Amplification Technologies market has also been witnessing an increase in the miniaturization of nucleic acid-based diagnostics. However, the tough competition from PCR-based diagnostics could pose a challenge to the growth of this market. The key vendors dominating this space are Becton, Dickson and Co., bioMerieux S.A., Hologic Inc., Novartis International AG., and Quidel Corp. The other vendors mentioned in the report are Alere Inc., Axxin Pvt Ltd., Eiken Chemical Co. Ltd., Great Basin Corp., Lucigen Corp., Meridian Bioscience Inc., New England Biolabs Inc., and Optigene Ltd. Commenting on the report, an analyst from the team said: The Molecular Diagnostics industry is experiencing a rapid shift toward an increase in the process automation and integration of sample analysis in single miniaturized devices. Miniaturization offers scope for reduced sample volume, enabling the end-user to automate and analyze the sample. Among all the diagnostic methods, nucleic acid testing remains the method with the most potential for conducting analysis in miniaturized devices. Although PCR is one of the standard techniques for conducting amplification reaction, the method is quite complex due to the need for repeated thermo cycling and cooling, and it consumes more energy in the process. As an alternative to PCR, isothermal nucleic amplification circumvents the need for repeated denaturation and cooling as the amplification reaction occurs under isothermal conditions. This greatly aids in the design of microfluidic chips for conducting molecular diagnostics. Most of these microfluidic devices adopting isothermal nucleic acid amplification methods are in the R&D phase. It is expected that the increase in miniaturization of nucleic acid-based diagnostics will boost the growth of the market. For more information visit http://www.researchandmarkets.com/research/4h...isothermal About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Favorable Court Judgments, Stock Price Updates, and Upcoming Investors Conferences - Analyst Notes on Salix, Cerner, Hologic, Covance, and Synta
PR Newswire - Thu Mar 06, 8:20AM CST
Today, Analysts Review released its analysts' notes regarding Salix Pharmaceuticals Ltd. (NASDAQ: SLXP), Cerner Corporation (NASDAQ: CENR), Hologic Inc. (NASDAQ: HOLX), Covance Inc. (NYSE: CVD), and Synta Pharmaceuticals Corp. (NASDAQ: SNTA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Hologic Announces Positive Results of February AMA CPT Editorial Panel Meeting
PR Newswire - Thu Mar 06, 6:00AM CST
Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products with an emphasis on serving the healthcare needs of women, announced today that the American Medical Association (AMA) CPT Editorial Panel posted its Summary of Panel Actions from the February, 2014 Panel Meeting.
Global Biopsy Devices Market Value to Grow Moderately by 2019, with Emerging Countries Increasing their Shares
M2 - Wed Mar 05, 3:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/qtvmxw/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - Global Analysis and Market Forecasts" report to their offering. The global biopsy devices market value will increase at a modest rate over the coming years, climbing from $506.4 million in 2013 to $602.4 million by 2019, at a Compound Annual Growth Rate (CAGR) of 2.93% The biopsy devices market in emerging economies, such as China, India and Brazil, will increase at much higher CAGRS than the global rate, reaching shares of 24%, 10% and 6% by 2019, respectively. Despite the modest global growth, several barriers are dampening the potential adoption of biopsy devices within a number of markets. Notably in the US, reimbursement for image-guided breast biopsies has undergone drastic cuts, which The authors expects will have a significant effect on the adoption of more expensive vacuum-assisted biopsy (VAB) devices. Joseph Gregory, the analyst covering Surgical Devices, says: Additionally, routine screening for prostate cancer and breast cancer has come under scrutiny, as sophisticated clinical trials reveal that these interventions have a minimal impact on the cancer related mortality. This is a long-term setback for the adoption of biopsy devices in diagnosing these cancers, given that these criticisms could curb adoption of routine screening. While these challenges are likely to affect the biopsy devices market, The authors believes that current and future players can still position themselves to obtain a competitive advantage. The major European countries have general mass-screening programs for breast cancer detection and will be increasing their adoption of VAB devices over the forecast period. Additionally, the emerging economies are increasing their access to healthcare resources and showing a preference for more expensive core needle biopsy devices over fine needle aspiration devices, Gregory concludes. This report and forecast focuses on the adoption patterns of surgical biopsies, fine needle aspiration (FNA) devices, core needle biopsy (CNB) devices, and vacuum-assisted biopsy (VAB) devices in the diagnosis of breast, prostate, lung, liver, and thyroid cancers. Countries covered include the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China, and India. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Unmet Needs Market Opportunity Analysis Market Drivers and Barriers Competitive Assessment Pipeline Assessment Clinical Trial Analysis Current and Future Players Market Outlook Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/qt...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Three New Peer-reviewed Publications Further Validate the Benefits of Hologic 3D Mammography (Tomosynthesis) in Breast Cancer Screening
PR Newswire Europe - Wed Mar 05, 3:01AM CST
- Research Supports the Use of Hologic's Lower Dose 3D Mammography Technology and the Continued Use of Two-views Over One in Breast Cancer Screening
Concise Analysis of the Future Prospects of Global Personalized Medicine Market
M2 - Tue Mar 04, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/zpctsr/future_prospects) has announced the addition of the "Concise Analysis of the Future Prospects of Global Personalized Medicine Market" report to their offering. Over the years, the Global Personalized Medicine market has been witnessing the emergence of various tools and technologies from the reputed vendors. For instance, AssureRx Health Inc. launched GeneSightRx ADHD in May 2012, a personalized medicine test for the growing number of children and adults diagnosed with ADHD. Moreover, Bristol-Myers Squibb Co. collaborated with MMRF in December 2012 for advanced personalized medicine for multiple Myeloma. Further, Alacris Theranostics GmbH entered into an agreement with GlaxoSmithKline plc in November 2012 to use ModCell system for early stage cancer research. Further, AltheaDx Inc. launched FLT3 Mutation Assay in October 2012. Agendia N.V. launched ColoPrint microarray-based 18-gene expression signature in June 2012 for predicting the risk of distant recurrence for stage II colon cancer patients. The European Medicines Agency approved Zelboraf, manufactured by F. Hoffmann-La Roche Ltd., in December 2011. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis 17. Other Reports in this Series Companies Mentioned: - Abbott Laboratories - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Co. - Celgene Corp. - Daiichi Sankyo Co. Ltd. - Danaher Corp. - Eli Lilly and Co. - Evotec AG - F. Hoffmann-La Roche Ltd. - GE Healthcare Ltd. - Genelex Corp. - GlaxoSmithKline plc - Hologic Inc. - Johnson & Johnson - Laboratory Corporation of America Holdings - Life Technologies Corp. - Merck KGaA - Mitsubishi Tanabe Pharma Corp. - Myriad Genetics Inc. - Novartis AG - Novartis AG - PerkinElmer Inc. - Pfizer Inc. - Pfizer Inc. - Quest Diagnostics Inc. - Sanofi S.A. - Sanofi S.A. - Siemens Healthcare - Sigma-Aldrich Corp. - Takeda Pharmaceutical Co. Ltd. - Teva Pharmaceutical Industries Ltd. - Thermo Fisher Scientific Inc. - Transgenomic Inc. For more information visit http://www.researchandmarkets.com/research/zp..._prospects
MediPoint: Biopsy Devices - Current and Future Players Report
M2 - Tue Mar 04, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/t5nxz6/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - Current and Future Players" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. The report identifies and analyzes the key companies shaping and driving the global Biopsy Devices market. The report provides insight into the competitive Biopsy Devices landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by Our team of industry experts. Scope - Investigation of current and future market competition for Biopsy Devices. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Biopsy Devices devices in clinical practice. Key Topics Covered: List of Tables List of Figures Introduction Competitive Assessment Pipeline Assessment Current and Future Players Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/t5...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Hologic's Total Breast Tomosynthesis Solution and Other Leading-edge Products to be Featured at the European Congress of Radiology in Vienna
PR Newswire - Mon Mar 03, 7:00AM CST
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, will showcase its extensive portfolio of innovative products for breast cancer screening and diagnosis, breast biopsy, osteoporosis risk assessment, and extremity imaging at the annual meeting of the European Society of Radiology, in Vienna, Austria March 6th through 10th. The European Congress of Radiology (ECR), the largest medical imaging meeting in Europe, annually attracts over 20,000 participants representing the medical specialty of radiology throughout Europe and many other countries of the world.
European Gynecological Device Market Research Report
M2 - Mon Mar 03, 3:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/g6pprd/european) has announced the addition of the "European Gynecological Device Market" report to their offering. The European gynecological device market is expected to reach over 290 million by 2020. This report covers assisted reproduction, global endometrial ablation, endometrial resection, uterine fibroid embolization, hysteroscopes, colposcopes, transcervical female sterilization, female urinary incontinence slings, fluid management, pelvic organ prolapse repair and hysterosalpingography (HSG) catheters. Despite some instability with regards to the European economy, the gynecological device market is expected to increase over the forecast period. The majority of markets covered in this report are expected to see positive increases in sales. However, declines in ASP will slightly offset these gains. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market'. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Key Topics Covered: Executive Summary Research Methodology European Gynecological Device Market Overview Country Profiles Assisted Reproduction Device Market Global Endometrial Ablation Market Endometrial Resection Device Market Uterine Fibroid Embolization Device Market Hysteroscope Market Colposcope Market Transcervical Female Sterilization Market Female Urinary Incontinence Sling Market Fluid Management Equipment Market Pelvic Organ Prolapse Repair Device Market Hysterosalpingography Catheter Market Abbreviations Companies Mentioned - American Medical Systems - Boston Scientific - C. R. Bard - Carl Zeiss - CeloNova - Coloplast - Conceptus - Cook Medical - Cooper Surgical - Hologic - Johnson & Johnson - Kaps Optik GmbH - Karl Storz - Merit Medical Systems - Olympus - Richard Wolf - Vitrolife For more information visit http://www.researchandmarkets.com/research/g6pprd/european About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Markets for Gynecological Devices Research Report
M2 - Mon Mar 03, 3:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/cknxxc/european_markets) has announced the addition of the "European Markets for Gynecological Devices (Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.) (Executive Summary)" report to their offering. This executive summary relates to the report European Gynecological Device Market. The European gynecological device market is expected to reach over 290 million by 2020. This report covers assisted reproduction, global endometrial ablation, endometrial resection, uterine fibroid embolization, hysteroscopes, colposcopes, transcervical female sterilization, female urinary incontinence slings, fluid management, pelvic organ prolapse repair and hysterosalpingography (HSG) catheters. Despite some instability with regards to the European economy, the gynecological device market is expected to increase over the forecast period. The majority of markets covered in this report are expected to see positive increases in sales. However, declines in ASP will slightly offset these gains. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market'. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Key Topics Covered: Executive Summary European Gynecological Device Market Trend Analysis Assisted Reproduction Device Market Global Endometrial Ablation Market Colposcope Market Female Urinary Incontinence Market Fluid Management Equipment Market Pelvic Organ Prolapse Repair Device Market Hysterosalpingography (Hsg) Catheter Market Competitive Analysis Companies Mentioned - American Medical Systems - Boston Scientific - C. R. Bard - Carl Zeiss - CeloNova - Coloplast - Conceptus - Cook Medical - Cooper Surgical - Hologic - Johnson & Johnson - Kaps Optik GmbH - Karl Storz - Merit Medical Systems - Olympus - Richard Wolf - Vitrolife For more information visit http://www.researchandmarkets.com/research/ck...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
In 2013, the European Market for Female Neonatal Diagnostic Devices was Valued at Over 410 Million
M2 - Fri Feb 28, 10:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/dj9zpl/european_markets) has announced the addition of the "European Markets for Female and Neonatal Diagnostic Devices" report to their offering. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, infant warmers and incubators. Europe's economic climate will continue to influence the many different sectors examined in this report. Capital equipment sales will be negatively influenced by health care restraints due to economic instability; this effect will be particularly pronounced in the more pricesensitive Southern European countries. The well- established and mature OB/GYN ultrasound segment will continue to dominate this market throughout the forecast period. This will be followed by the breast imaging segment, representing just over a quarter of the overall market. This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Main Segments Included - European Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Gynecology Ultrasound Market - Infant Warmer and Incubator Market Companies Mentioned - Agfa - Anthem - Ardo Medical AG - Argon Medical - Atom Medical International - B. Braun - BK Medical - Biosound Esaote - Brestige - C .R. Bard - CareFusion - Carestream - Cobams - Cooper Surgical - DMS Group - Demetech - Devicor - Draeger Medical - Echosens - Ethicon Endo-Surgery - Fisher & Paykel - Fujifilm - Fujifilm-SonoSite - Fukuda Denshi - GE Healthcare - Ginevri - Heinen-Lowenstein - Hitachi Medical Systems - Hitachi-Aloka - Hologic - IMS Giotto - International Biomedical - Invivo Interventional Instruments - Johnson & Johnson - Konica Minolta - Machnet - Mammotome - Medical ECONET - Mermaid Medical - Metaltronica - Mindray - Mediprema - NORAS - Natus Medical - Osteometer Meditech - Philips Healthcare - Planmed - Planmed OY - Samsung Medison - Siemens Healthcare - Sunlight Medical - Supersonic Imagine - Toshiba - Ultrasonix - Weyer - Zonare Medical Systems For more information visit http://www.researchandmarkets.com/research/dj...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets: Global Digital Breast Tomosynthesis Market to 2018 with Hologic, GE, Siemens & Internazionale Medico Scientifica Dominating
Business Wire - Thu Feb 27, 1:21PM CST
Research and Markets (http://www.researchandmarkets.com/research/j89vvq/global_digital) has announced the addition of the "Global Digital Breast Tomosynthesis Market to 2018 with Hologic, GE, Siemens & Internazionale Medico Scientifica Dominating" report to their offering.
Global Digital Breast Tomosynthesis Market to 2018 with Hologic, GE, Siemens & Internazionale Medico Scientifica Dominating
M2 - Thu Feb 27, 5:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/zs3twc/global_digital) has announced the addition of the "Global Digital Breast Tomosynthesis Market to 2018 with Hologic, GE, Siemens & Internazionale Medico Scientifica Dominating" report to their offering. The use of DBT to diagnose breast cancer in patients with dense breasts is an emerging trend in the Global DBT market. Although mammography still remains the best imaging technique for detecting breast cancer, it can fail to detect 37-70 percent of breast cancer cases in women with dense breasts. As a result, there can be a delay in diagnosis for women with dense breast tissues. DBT enables the removal of overlapping tissue artifacts, especially in dense breasts, and offers better screening sensitivity. Thus, increased use of DBT for patients with dense breasts will fuel the demand for DBT equipment in the Diagnostic industry. According to the report, one of the main drivers in this market is the increase in the incidence of breast cancer among women, which has led to an increase in demand for imaging equipment such as breast tomosynthesis devices. Further, the report states that one of the major challenges faced by the market is the lack of reimbursement policies for breast imaging through DBT for breast cancer diagnosis. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Clinical Advantages of DBT Equipment 08. Regulatory Environment 09. Geographical Segmentation 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/zs...al_digital